Deborah Weitzman
At a glance: Deborah Weitzman is CEO at Cardinal Health (CAH). Their latest SEC Form 4, filed Aug 20, 2026, reported a sale of $1.6M. On file: 0 purchase lines ($0) and 3 sale lines ($1.7M).
Disclosed holdings: about $21.4M of CAH stock: 77,901 shares reported on their latest Form 4 (filed Aug 20, 2026), valued at the Nov 20, 2026 close of $275.21. This counts only CAH shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
CEO at Cardinal Health Inc (CAH)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Deborah Weitzman's InsiderPrint
3 trades from SEC Form 4 filings, 2026 to 2026, drawn as one fingerprint.
Reading this print: Almost only sells, trading about 3 times a year, typically $97K a trade.
- Bump outward: a purchase (0)
- Dent inward: a sale (3)
- One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.
Insiders with a similar print
- Ian CleminsonCFO · IOSP · 100% match
- Chen Seng HengDirector · SE · 100% match
- Martin Bradley WingesCEO · HTH · 100% match
- David L. BumgarnerCFO · CHCO · 100% match
- Geoffrey PhillipsSr. Vp, Operations · GATX · 100% match
Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.
Reported trades
Follow Deborah Weitzman
Get one email when Deborah Weitzman files a new purchase or sale. Free.
At most one email a day about Deborah Weitzman, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.